Oral Syringes Market By Product Type (Disposable Oral Syringes, Reusable Oral Syringes); By Material (Polypropylene, Polyethylene, Silicone); By End User (Hospitals and Clinics, Home Healthcare, Pharmaceutical Companies) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
The oral syringes market was valued at USD 1709 million in 2024 and is projected to reach USD 2758.39 million by 2032, growing at a CAGR of 6.17% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Oral Syringes Market Size 2024
USD 1709 million
Oral Syringes Market, CAGR
6.17%
Oral Syringes Market Size 2032
USD 2758.39 million
Oral Syringes Market Insights
Market growth is driven by demand for accurate oral dosing and infection control, with disposable oral syringes leading the product type segment at a market share of 63.4%.
Key trends include expansion of home healthcare and improved syringe design, while polypropylene dominates materials with a market share of 46.7% due to durability and clarity.
Competitive activity centers on safety, scale, and distribution strength, while environmental concerns and price sensitivity act as key restraints in cost-focused regions.
North America leads with a market share of 36.2%, followed by Europe at 28.7% and Asia Pacific at 24.1%, supported by healthcare access, safety standards, and demographic demand.
Oral Syringes Market Segmentation Analysis:
By Product Type
By product type, disposable oral syringes dominate the oral syringes market with a market share of 63.4%. Healthcare providers prefer disposable options to reduce cross-contamination risk and improve patient safety. Single-use syringes support infection control protocols in hospitals and clinics. Rising medication administration in pediatric and geriatric care increases demand. Cost efficiency and ease of disposal further support adoption. Reusable oral syringes remain relevant in controlled home settings but face sterilization concerns. Disposable oral syringes maintain leadership due to regulatory focus on hygiene, high patient turnover, and growing emphasis on safe drug delivery practices.
For instance, BD manufactures disposable oral syringes designed for the accurate measurement and administration of non-injectable liquid medications. These syringes are validated for quality and accuracy to ensure reliable dosing and prevent leakage when used according to their intended single-use labeling.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
By material, polypropylene holds the largest share at 46.7% of the oral syringes market. Manufacturers favor polypropylene for durability, chemical resistance, and clarity. The material supports accurate dosage markings and smooth plunger movement. Polypropylene syringes suit liquid medications and repeated handling. Polyethylene follows due to flexibility and lower cost, while silicone remains niche for premium applications. Regulatory acceptance and compatibility with pharmaceutical formulations strengthen polypropylene usage. This material remains dominant due to consistent performance, manufacturing efficiency, and wide acceptance across healthcare and pharmaceutical applications.
For instance, B. Braun Melsungen AG produces polypropylene oral syringes that meet ISO 7886 requirements and withstand autoclave exposure up to 121 °C in validation tests.
By End User
By end user, hospitals and clinics account for a market share of 52.8%, leading oral syringe consumption. High patient volumes and frequent oral medication administration drive demand. Hospitals rely on oral syringes for accurate dosing, especially in pediatrics. Infection prevention standards favor single-use products. Home healthcare follows due to chronic care and aging populations. Pharmaceutical companies use oral syringes for packaging and clinical trials. Hospitals and clinics retain dominance due to continuous usage cycles, safety protocols, and standardized medication administration practices.
Key Growth Drivers
Rising Demand for Accurate Oral Drug Administration
Healthcare systems increasingly prioritize precise dosing for liquid medications to reduce treatment errors. Oral syringes enable accurate measurement compared with cups or spoons, improving medication safety. Pediatric and geriatric patients benefit the most from controlled dosing. Hospitals rely on oral syringes for antibiotics, pain relief, and nutritional supplements. Regulatory guidelines promote safe oral drug delivery practices. Growing use of liquid formulations further supports demand. Clinicians and caregivers prefer oral syringes for consistency and ease of use. This driver continues to support steady adoption across hospitals, clinics, and outpatient care settings worldwide.
For instance, Terumo Corporation designed oral syringes with precise graduation intervals and validated consistent plunger movement during internal performance tests to ensure accurate medication delivery.
Expansion of Pediatric and Geriatric Care Services
Global demographic trends strongly influence oral syringe demand. Pediatric care requires precise dosing due to low tolerance for dosage errors. Geriatric patients often use liquid medicines because of swallowing difficulties. Hospitals use oral syringes in neonatal, pediatric, and elderly wards. Home caregivers rely on oral syringes for daily medication routines. Rising life expectancy increases chronic disease prevalence among older adults. Pediatric population growth in developing regions also contributes. This driver expands usage across institutional and home healthcare environments. Demographic shifts ensure long-term demand growth for oral syringes.
For instance, Baxter International supplies specialized enteral syringes and infusion systems designed for use in neonatal and geriatric care settings, ensuring precise medication delivery and compatibility with safety-focused connectors to prevent misconnections.
Increased Focus on Infection Control and Patient Safety
Infection prevention remains a top priority in healthcare settings. Disposable oral syringes reduce cross-contamination risks compared with reusable devices. Hospitals adopt single-use syringes to comply with hygiene standards. Regulatory authorities promote safer medication administration tools. Growing awareness of hospital-acquired infections supports disposable product adoption. Patient safety programs emphasize error reduction and cleanliness. This driver strengthens demand across hospitals and clinics. Focus on infection control continues to influence procurement policies and supports sustained market growth.
Key Trends & Opportunities
Growth of Home Healthcare and Self-Administration
Home healthcare services expand due to aging populations and chronic disease management. Patients increasingly administer medications at home. Oral syringes support safe and accurate self-administration. Caregivers value clear markings and ease of handling. Home treatment reduces hospital visits and healthcare costs. This trend creates opportunities for consumer-focused designs. Manufacturers target home users with simple, ergonomic products. Expansion of home healthcare broadens the oral syringes market beyond institutional buyers.
For instance, Medline Industries supplies oral syringes for home use featuring easy-to-read graduations and clear labeling to distinguish them from other medical devices. These syringes are designed with low-dose reservoirs and specific tip styles to assist with the accurate measurement and delivery of liquid medication.
Product Innovation in Materials and Design
Manufacturers focus on improving syringe usability and safety. Innovations include smoother plungers, clearer graduations, and better grip designs. Child-resistant features attract pediatric care providers. Material advancements improve durability and chemical compatibility. Silicone and advanced polymers gain attention for premium products. Design innovation helps brands differentiate in competitive markets. This trend supports value-added offerings and strengthens product portfolios. Continuous innovation creates opportunities for premium pricing and wider adoption.
For instance, Nipro Corporation developed oral syringes featuring low-friction plungers and specialized gaskets designed to maintain seal integrity and dimensional stability during use.
Key Challenges
Environmental Concerns Related to Disposable Products
Widespread use of disposable oral syringes increases medical plastic waste. Environmental regulations pressure healthcare providers to reduce waste. Sustainable alternatives remain limited and costly. Disposal and recycling challenges affect hospital operations. Environmental concerns influence procurement decisions in some regions. Manufacturers face pressure to develop eco-friendly materials. This challenge may limit long-term growth of disposable products. Balancing safety and sustainability remains a key industry issue.
Price Sensitivity in Developing Regions
Cost remains a major concern in low- and middle-income countries. Healthcare budgets often prioritize essential medicines over devices. Reusable oral syringes compete due to lower upfront costs. Price sensitivity affects large-scale procurement decisions. Limited reimbursement restricts adoption of premium products. Manufacturers must balance affordability and quality. This challenge slows market penetration in cost-sensitive regions and impacts overall growth pace.
Regional Analysis
North America
North America holds a market share of 36.2% in the oral syringes market, driven by strong healthcare infrastructure and strict patient safety standards. Hospitals and clinics widely use oral syringes for pediatric and geriatric medication delivery. High awareness of dosing accuracy supports steady demand. Regulatory focus on infection control increases preference for disposable oral syringes. Home healthcare adoption also supports market growth. The United States leads regional demand due to high healthcare spending and advanced clinical practices, while Canada contributes through expanding elderly care services and rising use of home-based medication administration devices.
Europe
Europe accounts for a market share of 28.7%, supported by well-established healthcare systems and strong regulatory oversight. Countries such as Germany, France, and the United Kingdom drive demand for accurate oral drug delivery devices. Hospitals emphasize patient safety and hygiene, supporting disposable syringe adoption. Aging populations increase medication usage across long-term care facilities. Home healthcare services continue to expand. Environmental considerations influence material selection and waste management. Europe benefits from standardized healthcare protocols, steady pharmaceutical activity, and consistent demand for safe and precise oral medication administration solutions.
Asia Pacific
Asia Pacific holds a market share of 24.1%, reflecting rising healthcare access and growing population base. Increasing pediatric care needs and expanding elderly populations drive demand for oral syringes. Governments invest in healthcare infrastructure and maternal care programs. Hospitals and clinics adopt oral syringes to improve medication accuracy. Home healthcare usage grows in urban areas. Countries such as China, India, and Japan lead regional growth. Cost-effective products gain traction. Asia Pacific shows strong growth potential due to expanding healthcare services and rising awareness of safe medication delivery.
Rest of the World
The Rest of the World region accounts for a market share of 11.0%, supported by gradual healthcare development. Latin America shows growing demand due to improving hospital infrastructure and pediatric care services. The Middle East benefits from healthcare modernization and hospital expansion. Africa remains at an early adoption stage with limited access in rural areas. International aid programs support medication safety initiatives. Demand focuses on affordable and disposable oral syringes. Although smaller in scale, the region offers long-term growth opportunities driven by improving healthcare access and medication safety awareness.
Oral Syringes Market Segmentations:
By Product Type
Disposable oral syringes
Reusable oral syringes
By Material
Polypropylene
Polyethylene
Silicone
By End User
Hospitals and clinics
Home healthcare
Pharmaceutical companies
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Competitive Landscape
Competitive landscape analysis highlights competition led by BD (Becton, Dickinson and Company), B. Braun Melsungen AG, Terumo Corporation, Cardinal Health, and Medline Industries. These companies compete on product quality, safety compliance, and large-scale manufacturing capability. Market leaders focus on disposable oral syringes to meet infection control standards and regulatory expectations. Strong hospital and pharmaceutical distribution networks provide competitive advantage. Manufacturers invest in material innovation, clear dosage markings, and ergonomic designs to improve usability. Pricing efficiency remains critical in public healthcare procurement. Regional players compete through cost-effective offerings and local supply contracts. Partnerships with hospitals and pharmaceutical firms support stable demand. Overall competition remains moderately consolidated, driven by patient safety focus, regulatory compliance, and growing demand for accurate oral medication delivery devices.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In July 2025, Terumo Corporation announced a commercial launch for an injection delivery system. The update reflects ongoing syringe-based delivery innovation.
In January 2025, BD (Becton, Dickinson and Company) announced new U.S. investments to add capacity for critical devices, including syringes.
In February 2024, Cardinal Health announced a voluntary recall expansion for Monoject sterile syringes, including ENFit enteral syringes.
Report Coverage
The research report offers an in-depth analysis based on Product Type,Material, End Userand Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope 2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology 3. Executive Summary 4. Introduction
4.1. Overview
4.2. Key Industry Trends 5. Global Oral Syringes Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast 6. Market Breakup by Product Type
6.1. Disposable Oral Syringes
6.1.1. Market Trends
6.1.2. Market Forecast
6.1.3. Revenue Share
6.1.4. Revenue Growth Opportunity
6.2. Reusable Oral Syringes
6.2.1. Market Trends
6.2.2. Market Forecast
6.2.3. Revenue Share
6.2.4. Revenue Growth Opportunity 7. Market Breakup by Material
7.1. Polypropylene
7.1.1. Market Trends
7.1.2. Market Forecast
7.1.3. Revenue Share
7.1.4. Revenue Growth Opportunity
7.2. Polyethylene
7.2.1. Market Trends
7.2.2. Market Forecast
7.2.3. Revenue Share
7.2.4. Revenue Growth Opportunity
7.3. Silicone
7.3.1. Market Trends
7.3.2. Market Forecast
7.3.3. Revenue Share
7.3.4. Revenue Growth Opportunity 8. Market Breakup by End User
8.1. Hospitals and Clinics
8.1.1. Market Trends
8.1.2. Market Forecast
8.1.3. Revenue Share
8.1.4. Revenue Growth Opportunity
8.2. Home Healthcare
8.2.1. Market Trends
8.2.2. Market Forecast
8.2.3. Revenue Share
8.2.4. Revenue Growth Opportunity
8.3. Pharmaceutical Companies
8.3.1. Market Trends
8.3.2. Market Forecast
8.3.3. Revenue Share
8.3.4. Revenue Growth Opportunity 9. Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Southeast Asia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast 10. SWOT Analysis
10.1. Overview
10.2. Strengths
10.3. Weaknesses
10.4. Opportunities
10.5. Threats 11. Value Chain Analysis 12. Porter’s Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes 13. Price Analysis 14. Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. BD (Becton, Dickinson and Company)
14.3.2. B. Braun Melsungen AG
14.3.3. Terumo Corporation
14.3.4. Cardinal Health
14.3.5. Smiths Medical
14.3.6. Nipro Corporation
14.3.7. Medline Industries
14.3.8. Hindustan Syringes & Medical Devices
14.3.9. Baxter International
14.3.10. Fresenius Kabi 15. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions
What is the current market size for Oral Syringes market, and what is its projected size in 2032?
The Oral Syringes market size was USD 1709 million in 2024 and is projected to reach USD 2758.39 million by 2032.
At what Compound Annual Growth Rate is the Oral Syringes market projected to grow between 2024 and 2032?
The Oral Syringes market is projected to grow at a CAGR of 6.17% during the forecast period.
Which Oral Syringes market segment held the largest share in 2024?
Disposable oral syringes held the largest share in the Oral Syringes market in 2024.
What are the primary factors fueling the growth of the Oral Syringes market?
Key growth factors of the Oral Syringes market include demand for accurate oral dosing, infection control focus, and pediatric care growth.
Who are the leading companies in the Oral Syringes market?
Leading companies in the Oral Syringes market include BD, B. Braun Melsungen AG, Terumo Corporation, Cardinal Health, and Medline Industries.
Which region commanded the largest share of the Oral Syringes market in 2024?
North America commanded the largest share of the Oral Syringes market in 2024.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The Oral Macromolecular Formulation market size was valued at USD 9 million in 2024 and is projected to reach USD 12.51 million by 2032, reflecting a CAGR of 4.8% during the forecast period.
The implantable defibrillator market was valued at USD 4,394.5 million in 2024 and is expected to reach USD 7,164.33 million by 2032, growing at a CAGR of 6.3% during the forecast period.
The Ineffective Esophageal Motility Treatment market size was valued at USD 4,680 million in 2024 and is projected to reach USD 7,402.47 million by 2032, growing at a CAGR of 5.9% during the forecast period.
Erucamide market size was valued at USD 264 million in 2024 and is projected to reach USD 359.25 million by 2032, reflecting a CAGR of 3.93% during the forecast period.
The Cervical Cancer Screening market was valued at USD 1,557.00 million in 2024 and is anticipated to reach USD 2,444.5 million by 2032, registering a CAGR of 5.8% during the forecast period.
At Home Pregnancy Testing market size was valued at USD 730.5 million in 2024 and is anticipated to reach USD 1,007.5 million by 2032, growing at a CAGR of 4.1% during the forecast period.
At Home Molecular Testing market size was valued at USD 10,809 million in 2024 and is anticipated to reach USD 16,463.2 million by 2032, growing at a CAGR of 5.4% during the forecast period.
The Anti-Hyperglycemic Agents market size stood at USD 91,333 million in 2024. Analysts expect the market value to rise to USD 128,893.4 million by 2032. The industry is set to grow at a CAGR of 4.4% during the forecast period.
The Automated Microscopy market size reached USD 8,095 million in 2024 and is expected to reach USD 13,128.3 million by 2032, expanding at a CAGR of 6.23% during the forecast period.
The Clinical Rollators market size reached USD 2,016 million in 2024 and is projected to reach USD 3,760.07 million by 2032, advancing at a CAGR of 8.1% during the forecast period.
The wound filler market was valued at USD 607.5 million in 2024 and is expected to reach USD 844.3 million by 2032, growing at a CAGR of 4.2% during the forecast period.
The Smart Wheelchair market was valued at USD 177.5 million in 2024 and is anticipated to reach USD 333.4 million by 2032, growing at a CAGR of 8.2% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
